Search results
National-debt interest now costs more than Medicare or defense
Market Watch· 3 days agoThink of the national debt as an interest-only mortgage. It was even bigger than everything we spent...
Greenwich Village Medicare navigation startup raises $50M Series C
Crain's New York Business· 2 days agoThe funding round was led by the San Francisco-based firm XYZ Venture Capital, with participation from existing investors Narya Capital, Addition, Susa Ventures, and Maverick Ventures. Chapter ...
Interest costs on the national debt just surpassed spending on defense, Medicare
FOX Business· 1 hour agoInterest payments on the nation’s ballooning debt just eclipsed spending on defense and Medicare,...
What Medicare beneficiaries need to know about generic medications
Fortune via Yahoo Finance· 3 days agoThat’s why it’s important to do your research before buying a generic and enrolling in a Medicare...
TONI SAYS: Please simplify Medicare’s enrollment process
Odessa American· 2 days agoMy friends are advising me if I do not sign up for Medicare when I turn 65, I will be making a major Medicare mistake. Can you please simplify the
Aetna vs. Anthem: Medicare Advantage Comparison - NerdWallet
Nerdwallet· 3 days agoAetna offers Medicare Advantage plans in more states and covers nearly twice as many members as...
Amid uncertainty around Social Security, here's what financial advisers are telling clients
Yahoo Finance· 8 hours agoTo me, it's better to do it that way and be over-prepared than under-prepared.” One of people...by...
Kaiser Permanente vs. Anthem: Medicare Advantage Comparison - NerdWallet
Nerdwallet· 3 days agoKaiser Permanente’s star ratings are higher, while Anthem's member experience scores are better....
Report finds private health plans paid hospitals 254% of what Medicare would pay during 2022
Medical Xpress· 4 days agoPrices paid to hospitals during 2022 by employers and private insurers for both inpatient and...
Does Medicare Cover the RSV Vaccine?
US News Health· 3 days agoCDC recommends vaccination for higher-risk populations. Two vaccines – Arexvy and Abrysvo – are currently approved by the FDA for those ages 60 and older and offers protection for two years.